Skip to content
Menu

Century Therapeutics, Inc. IPSC

Full chart Compare
Set alert

Price alert · IPSC

All alert types
1.20 USD -0.13 (-9.47%)

As ofNov 20, 2026, 12:08 PM EST

1.18 Day range 1.22
0.49 52-week range 2.94
YTD
+20.10%
1 year
+143.38%

Revenue & Expenses

Revenue Profit Costs
Other Income$5.39MOther Operating Income$8.57MIncome Tax Benefit$68.00KGross Profit$96.06MNet Loss$9.58MCost of Revenue$13.10MExpenses$119.67MSelling, General & Admin$24.00MResearch & Development$95.67MRevenue$109.16M

Latest period ending Dec 31, 2025 · select a line to chart its full history

IPSC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
109.16M6.59M2.23M5.20M0
109.16M6.59M2.23M5.20M0
-17.27M-138.14M-146.55M-133.83M-94.88M
-9.58M-126.57M-136.67M-130.93M-95.82M
-0.14-1.61-2.30-2.27-2.96
IPSC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
64.21M61.21M49.30M86.24M58.16M
223.70M353.22M360.69M486.54M437.38M
64.77M191.85M175.94M183.81M41.14M
40.24M48.96M46.66M48.94M24.50M
158.94M161.36M184.75M302.74M396.24M
IPSC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-103.88M-110.14M-88.35M14.05M-89.00M
107.50M47.48M61.13M-13.13M-298.34M
173.00K74.56M-9.72M27.16M417.77M
-848.00K-154.00K-13.74M-30.60M-44.97M
3.80M11.91M-36.94M28.08M30.43M